Diazoxide (Proglycem) Oral liq 50 mg per ml: Supply issue

Supply issue Active

Supplies of diazoxide oral liquid are constrained.

Affected product

After being alerted by a pharmacist, Pharmac has been able to confirm with Link Pharmaceuticals that there is limited stock at the wholesaler level of diazoxide (Proglycem) Oral liq 50 mg per ml (pharmacode 2457849).

Alternative product listed

Stock from Australia has been secured and will be in the country by 3 June 2022. Pharmac has listed the alternative brand (e5 Pharma Diazoxide) from 1 June 2022 (pharmacode 2635674). It will not appear in the Online Schedule until it's updated for July.

Link have secured a year's supply of this product. We may de-list the previous brand (Proglycem/2457849) if manufacturing does not resume.

e5 Pharma Diazoxide is not approved by Medsafe, neither is Proglycem. As such the rules around prescribing and dispensing a section 29 medicine need to be followed.

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website(external link)

What patients need to know about section 29 medicines – Health Navigator website(external link)

For pharmacies:

RxOne users: the listing will be automatically updated by RxOne from the effective date. 

TONIQ users: the listing will automatically be updated in Toniq medicine databases from the effective date. 

The Ministry of Health Sector Operations Group will be able to process claims for June dispensing of the above listings as per normal section 29 rules.

Who to contact

If pharmacies have difficulty accessing the product, contact Link Pharmaceuticals at customerservice@linkhealthcare.co.nz